The possibility of developing the next generation of prostate cancer therapies, which are targeted at metabolism, is being explored by a University of Houston (UH) scientist and his team. With approximately one out of six American men being diagnosed and nearly a quarter of a million new cases expected this year, prostate cancer is the most common malignancy among men in the U.S. Since prostate cancer relies on androgens for growth and survival, androgen ablation ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/1mQQCZW
No comments:
Post a Comment